Cubist Systematic Strategies LLC Buys Shares of 3,268 USANA Health Sciences, Inc. (USNA)

Cubist Systematic Strategies LLC bought a new position in USANA Health Sciences, Inc. (NYSE:USNA) during the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor bought 3,268 shares of the company’s stock, valued at approximately $189,000.

A number of other hedge funds have also recently modified their holdings of USNA. Rhumbline Advisers increased its position in USANA Health Sciences by 5.4% in the 2nd quarter. Rhumbline Advisers now owns 12,910 shares of the company’s stock worth $828,000 after purchasing an additional 664 shares during the last quarter. SG Americas Securities LLC acquired a new position in USANA Health Sciences in the 2nd quarter worth about $162,000. Bank of New York Mellon Corp increased its position in USANA Health Sciences by 13.4% in the 2nd quarter. Bank of New York Mellon Corp now owns 90,193 shares of the company’s stock worth $5,782,000 after purchasing an additional 10,670 shares during the last quarter. Legal & General Group Plc increased its position in USANA Health Sciences by 7.6% in the 2nd quarter. Legal & General Group Plc now owns 4,040 shares of the company’s stock worth $259,000 after purchasing an additional 284 shares during the last quarter. Finally, BNP Paribas Arbitrage SA increased its position in USANA Health Sciences by 13.1% in the 2nd quarter. BNP Paribas Arbitrage SA now owns 2,111 shares of the company’s stock worth $135,000 after purchasing an additional 245 shares during the last quarter. 43.82% of the stock is currently owned by institutional investors.

In other news, major shareholder Global Ltd Gull sold 45,216 shares of the stock in a transaction dated Wednesday, November 22nd. The stock was sold at an average price of $66.44, for a total transaction of $3,004,151.04. Following the transaction, the insider now owns 11,694,053 shares of the company’s stock, valued at approximately $776,952,881.32. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, Director Gilbert A. Fuller sold 1,710 shares of the stock in a transaction dated Thursday, October 26th. The shares were sold at an average price of $67.01, for a total value of $114,587.10. Following the transaction, the director now directly owns 1,710 shares in the company, valued at approximately $114,587.10. The disclosure for this sale can be found here. In the last three months, insiders have sold 623,752 shares of company stock worth $41,411,372. 53.20% of the stock is currently owned by insiders.

Several research analysts have weighed in on the company. BidaskClub lowered USANA Health Sciences from a “sell” rating to a “strong sell” rating in a research report on Friday, September 22nd. Pivotal Research upped their target price on USANA Health Sciences from $70.00 to $80.00 and gave the stock a “buy” rating in a research report on Wednesday, October 25th.

USANA Health Sciences, Inc. (NYSE:USNA) opened at $74.45 on Friday. USANA Health Sciences, Inc. has a 52-week low of $52.55 and a 52-week high of $76.15. The firm has a market capitalization of $1,790.00, a PE ratio of 20.51 and a beta of 1.06.

USANA Health Sciences (NYSE:USNA) last issued its quarterly earnings data on Tuesday, October 24th. The company reported $1.02 EPS for the quarter, beating the Zacks’ consensus estimate of $0.91 by $0.11. The business had revenue of $261.77 million for the quarter, compared to analyst estimates of $259.52 million. USANA Health Sciences had a return on equity of 26.38% and a net margin of 8.79%. The firm’s revenue for the quarter was up 3.0% on a year-over-year basis. During the same quarter in the prior year, the firm posted $2.40 EPS. equities research analysts predict that USANA Health Sciences, Inc. will post 3.7 EPS for the current year.

TRADEMARK VIOLATION NOTICE: This article was first reported by Sports Perspectives and is the property of of Sports Perspectives. If you are reading this article on another domain, it was copied illegally and reposted in violation of U.S. & international trademark and copyright laws. The correct version of this article can be read at https://sportsperspectives.com/2018/01/12/cubist-systematic-strategies-llc-buys-shares-of-3268-usana-health-sciences-inc-usna.html.

About USANA Health Sciences

USANA Health Sciences, Inc develops and manufactures science-based nutritional and personal care products. The Company operates as a direct selling company in two geographic regions: Americas and Europe, and Asia Pacific, which includes three sub-regions: Southeast Asia Pacific, Greater China and North Asia.

Want to see what other hedge funds are holding USNA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for USANA Health Sciences, Inc. (NYSE:USNA).

Institutional Ownership by Quarter for USANA Health Sciences (NYSE:USNA)

Receive News & Ratings for USANA Health Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for USANA Health Sciences and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply